Knowledge Hub

At Sterling, we are proud of our heritage, strong technical capabilities and compliance credentials but it’s our people and the genuine and passionate way they do business that makes us different.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) research and development bioconjugation services.

At Sterling we believe that whilst science can be complex, partnerships should be simple. That is why we have prepared a range of resources to share our team’s research and expertise, and to help you learn more about Sterling and the services we offer.

Filter Content

Knowledge Hub Articles

News

Sterling Expands Bioanalytical Capabilities at Deeside, UK Site

News

Sterling expands HPAPI capabilities to further strengthen integrated ADC services

News

Sterling wins Company of the Year at the Bionow annual awards

News

Sterling Partners with KGM Refrigeration to Install Breakthrough Sustainable Chilling Technology for API Manufacturing

News

Sterling Pharma Solutions Acquires UK Contract Research Organisation, NewChem Technologies

News

Sterling pioneers energy from waste